Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation

por Moss, Marcia L., Minond, Dmitry
Publicado 2017

Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain

por Miller, Miles A., Moss, Marcia L., Powell, Gary, Petrovich, Robert, Edwards, Lori, Meyer, Aaron S., Griffith, Linda G., Lauffenburger, Douglas A.
Publicado 2015

Development of flow cytometry assays for measuring cell-membrane enzyme activity on individual cells

por Gorry, Michael, Yoneyama, Toshie, Vujanovic, Lazar, Moss, Marcia L., Garlin, Michelle A., Miller, Miles A, Herman, James, Stabile, Laura P., Vujanovic, Nikola L.
Publicado 2020

Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates

por Yoneyama, Toshie, Gorry, Michael, Miller, Miles A, Gaither-Davis, Autumn, Lin, Yan, Moss, Marcia L., Griffith, Linda G., Lauffenburger, Douglas A., Stabile, Laura P., Herman, James G., Vujanovic, Nikola L.
Publicado 2017

ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker

por Yoneyama, Toshie, Gorry, Michael, Sobo-Vujanovic, Andrea, Lin, Yan, Vujanovic, Lazar, Gaither-Davis, Autumn, Moss, Marcia L., Miller, Miles A, Griffith, Linda G., Lauffenburger, Douglas A., Stabile, Laura P., Herman, James, Vujanovic, Nikola L.
Publicado 2018

ADAM8 as a drug target in Pancreatic Cancer

por Schlomann, Uwe, Koller, Garrit, Conrad, Catharina, Ferdous, Taheera, Golfi, Panagiota, Garcia, Adolfo Molejon, Höfling, Sabrina, Parsons, Maddy, Costa, Patricia, Soper, Robin, Bossard, Maud, Hagemann, Thorsten, Roshani, Rozita, Sewald, Norbert, Ketchem, Randal R., Moss, Marcia L., Rasmussen, Fred H., Miller, Miles A., Lauffenburger, Douglas A., Tuveson, David A., Nimsky, Christopher, Bartsch, Jörg W.
Publicado 2015